ZELBORAF for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 109 adverse event reports in the FDA FAERS database where ZELBORAF was used for Malignant melanoma.
Most Reported Side Effects for ZELBORAF
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 62 | 17.3% | 29 | 4 |
| Death | 49 | 13.7% | 49 | 4 |
| Rash | 45 | 12.6% | 4 | 10 |
| Arthralgia | 29 | 8.1% | 2 | 9 |
| Fatigue | 17 | 4.8% | 3 | 8 |
| Nausea | 16 | 4.5% | 3 | 10 |
| Asthenia | 14 | 3.9% | 2 | 4 |
| Dysphagia | 14 | 3.9% | 1 | 4 |
| Erythema | 14 | 3.9% | 4 | 2 |
| Photosensitivity reaction | 14 | 3.9% | 3 | 4 |
| Pyrexia | 13 | 3.6% | 1 | 6 |
| Diarrhoea | 12 | 3.4% | 4 | 6 |
| Pain in extremity | 12 | 3.4% | 1 | 5 |
| Drug ineffective | 11 | 3.1% | 6 | 3 |
| Malignant neoplasm progression | 11 | 3.1% | 7 | 2 |
Other Indications for ZELBORAF
Metastatic malignant melanoma (130)
Product used for unknown indication (90)
Neoplasm malignant (22)
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)